Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novarex

Novarex
2008 FOUNDED
PUBLIC STATUS
201-300 EMPLOYEES
194700 STOCK SYMBOL
$19.53 SHARE PRICE (As of Monday Closing)
Description

Novarex Co Ltd offers dietary supplements including Lactomin, Probiotics, Microencapsulation, Health Supplement, Dietary Supplement, Nutrition, Omega-3, Vitamin, among others.

Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Primary Industry
Food Products
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Stock Exchange
KRX
Primary Office
  • 94, Gak-ri 1-gil, Ochang-eup
  • Cheongwun-gu
  • Cheongiu-si, Chungcheongbuk-do
  • South Korea

+82 00000000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Novarex’s full profile, request a free trial.

Novarex Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$12.35 - $24.04 $155M $20.37 $1.12 134K 7.95M

Novarex Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 136,896 80,873
Revenue 103,256 97,635 71,301 66,197
EBITDA 12,416 11,923 9,667 10,337
Net Income 8,946 8,634 7,147 7,895
Total Assets 102,015 95,073 67,189 49,821
Total Debt 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Novarex Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Novarex‘s full profile, request access.

Request full access to PitchBook

Novarex Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Novarex‘s full profile, request access.

Request full access to PitchBook